0001641241-20-000001.txt : 20200917 0001641241-20-000001.hdr.sgml : 20200917 20200917171556 ACCESSION NUMBER: 0001641241-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200917 DATE AS OF CHANGE: 20200917 EFFECTIVENESS DATE: 20200917 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cyrus Biotechnology, Inc. CENTRAL INDEX KEY: 0001641241 IRS NUMBER: 471015686 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-375846 FILM NUMBER: 201181896 BUSINESS ADDRESS: STREET 1: 1201 BOYLSTON AVE. STREET 2: UNIT 417 CITY: SEATTLE STATE: WA ZIP: 98101 BUSINESS PHONE: 6178182334 MAIL ADDRESS: STREET 1: 1201 BOYLSTON AVE. STREET 2: UNIT 417 CITY: SEATTLE STATE: WA ZIP: 98101 D 1 primary_doc.xml X0708 D LIVE 0001641241 Cyrus Biotechnology, Inc. 500 Union Street Suite 320 SEATTLE WA WASHINGTON 98101 2062586561 DELAWARE None None Corporation true Lucas Nivon 500 Union Street Suite 320 Seattle WA WASHINGTON 98101 Executive Officer Director Promoter Yifan Song 500 Union Street Suite 320 Seattle WA WASHINGTON 98101 Executive Officer Director Promoter Gus Tai 500 Union Street Suite 320 Seattle WA WASHINGTON 98101 Director Eric Bell 500 Union Street Suite 320 Seattle WA WASHINGTON 98101 Director Chad Waite 500 Union Street Suite 320 Seattle WA WASHINGTON 98101 Director Other Technology Decline to Disclose 06b false 2020-09-04 false true false 0 1500000 1131000 369000 false 19 0 0 0 false Cyrus Biotechnology, Inc. Lucas Nivon Lucas Nivon Chief Executive Officer 2020-09-17